BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23189334)

  • 1. Retracted: Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium.
    Das M; Das S; Das DK
    J Cell Mol Med; 2012 Oct; 16(10):2547. PubMed ID: 23189334
    [No Abstract]   [Full Text] [Related]  

  • 2. Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium.
    Das M; Das S; Das DK
    J Cell Mol Med; 2007; 11(4):788-97. PubMed ID: 17760840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic preconditioning promotes the translocation of protein kinase C ε binding with caveolin-3 at cell membrane not mitochondrial in rat heart.
    Yu H; Yang Z; Pan S; Yang Y; Tian J; Wang L; Sun W
    Cell Cycle; 2015; 14(22):3557-65. PubMed ID: 26313243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.
    Das S; Otani H; Maulik N; Das DK
    J Mol Cell Cardiol; 2006 Aug; 41(2):248-55. PubMed ID: 16697003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of survival signal by differential interaction of p38MAPKalpha and p38MAPKbeta with caveolin-1 and caveolin-3 in the adapted heart.
    Das M; Cui J; Das DK
    J Mol Cell Cardiol; 2007 Jan; 42(1):206-13. PubMed ID: 17069850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning.
    Takeishi Y; Huang Q; Wang T; Glassman M; Yoshizumi M; Baines CP; Lee JD; Kawakatsu H; Che W; Lerner-Marmarosh N; Zhang C; Yan C; Ohta S; Walsh RA; Berk BC; Abe J
    J Mol Cell Cardiol; 2001 Nov; 33(11):1989-2005. PubMed ID: 11708843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction notice to "Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling" [J. Mol. Cell. Cardiol. 41 (2006) 248–255].
    J Mol Cell Cardiol; 2012 Nov; 53(5):742. PubMed ID: 23230603
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of p38 MAP kinase in myocardial stress.
    Nagarkatti DS; Sha'afi RI
    J Mol Cell Cardiol; 1998 Aug; 30(8):1651-64. PubMed ID: 9841266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin in cardioprotective effect of ischemic preconditioning.
    Sharma A; Singh M
    J Cardiovasc Pharmacol; 1999 May; 33(5):772-8. PubMed ID: 10226865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.
    Ren Z; Liang W; Chen C; Yang H; Singhal PC; Ding G
    Cell Signal; 2012 Feb; 24(2):443-450. PubMed ID: 21982880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart.
    Ajmani P; Yadav HN; Singh M; Sharma PL
    BMC Cardiovasc Disord; 2011 Jul; 11():43. PubMed ID: 21745415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning by angiotensin II: a tale of more than two kinases.
    Dawn B
    J Mol Cell Cardiol; 2006 Aug; 41(2):223-5. PubMed ID: 16793059
    [No Abstract]   [Full Text] [Related]  

  • 13. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.
    Cohen AW; Park DS; Woodman SE; Williams TM; Chandra M; Shirani J; Pereira de Souza A; Kitsis RN; Russell RG; Weiss LM; Tang B; Jelicks LA; Factor SM; Shtutin V; Tanowitz HB; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Feb; 284(2):C457-74. PubMed ID: 12388077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart.
    Sharma A; Singh M
    Eur J Pharmacol; 2000 Oct; 406(1):85-92. PubMed ID: 11011038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation].
    Miki T; Miura T; Tsuchida A; Nakano A; Hasegawa T; Fukuma T; Shimamoto K
    J Cardiol; 2001 Feb; 37(2):112-3. PubMed ID: 11255694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity.
    Engelman JA; Zhang XL; Razani B; Pestell RG; Lisanti MP
    J Biol Chem; 1999 Nov; 274(45):32333-41. PubMed ID: 10542274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of lipid raft in ischemic preconditioning.
    Das M; Gherghiceanu M; Lekli I; Mukherjee S; Popescu LM; Das DK
    Cell Physiol Biochem; 2008; 21(4):325-34. PubMed ID: 18441521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: the role of p38 MAP kinase.
    Cooper M; Ytrehus K
    Mol Cell Biochem; 2004 Apr; 259(1-2):83-90. PubMed ID: 15124911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts.
    Schorb W; Conrad KM; Singer HA; Dostal DE; Baker KM
    J Mol Cell Cardiol; 1995 May; 27(5):1151-60. PubMed ID: 7473773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
    Nuñez RE; Javadov S; Escobales N
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.